CN100334080C - Benzo-dihydropyran glycoside derivatives - Google Patents
Benzo-dihydropyran glycoside derivatives Download PDFInfo
- Publication number
- CN100334080C CN100334080C CNB2005100263775A CN200510026377A CN100334080C CN 100334080 C CN100334080 C CN 100334080C CN B2005100263775 A CNB2005100263775 A CN B2005100263775A CN 200510026377 A CN200510026377 A CN 200510026377A CN 100334080 C CN100334080 C CN 100334080C
- Authority
- CN
- China
- Prior art keywords
- pyranoglucose
- ethanoyl
- dimethyl
- synthetic
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention relates to a centchroman carbon glucoside derivative (a tocopherol compound or an analog thereof). the structure of the centchroman carbon glucoside derivative is disclosed in the specification. The derivative is prepared by that corresponding hydroquinone or corresponding phenol is used as a starting raw material to prepare the derivative through methylation, substitution by a 1, 2, 3, 4, 6-penta-O-acetyl-beta-D-pyranoglucose p-benzene ring, benzoquinone, hydroquinone, cyclisation and alcoholysis. In the formula (I), R1 and R3 are respectively selected from one of H, CH3 and (II); R2 is C1-C16 alkyl; R4 is H or CH3, wherein at least one of R1 and R3 is (III), but R1 and R3 are not (IV) simultaneously.
Description
Technical field
The present invention relates to a kind of benzo-dihydropyran glycoside derivatives.
Background technology
Tocopherols compound (vitamin-E) is the important compound of a class in the chroman derivatives, vitamin-E is as antioxidant the most outstanding in the organism and radical scavenger, medicine, food, feed have been widely used in, in the related industries such as makeup and material.
Yet, thereby limit its application because vitamin-E or its analogue is water-soluble very poor.Thereby it is water-soluble to improve it to introduce hydrophilic radical on vitamin-E, thereby obtains the amphiphatic vitamin-E of hydrophilic lipophilic tool, can promote the application that it is more wide greatly.Document Carbohydrate Research, 23,299,1997 and 72,325,2000 reports, with glucose or its oligosaccharides and vitamin-E direct synthesising complex E grape glycosyloxy glucosides under the catalysis of Lewis acid, its structure is as follows respectively:
N is an integer between the 0-6
Yet because the phenolic hydroxyl group on the vitamin-E parent chroman ring is most important to anti-oxidant activity, the destruction phenolic hydroxyl group just makes vitamin-E reduce greatly or loses anti-oxidant activity.The structure of above-mentioned bibliographical information has been just owing to destroyed hydroxyl on the chroman ring, thereby caused the low activity of these structures.In addition, the direct glucosides meeting of vitamin-E causes vitamin-E very easily oxidized, generates the oxidized byproduct of a series of following structures, thereby causes the reduction of productive rate.
Therefore, how keeping under chroman derivatives (tocopherols compound or its analogue) the anti-oxidant activity prerequisite, increasing it and water-solublely just become the technical issues that need to address of the present invention.
Summary of the invention
The present invention introduces pyranoglucose and obtains a class benzo-dihydropyran glycoside derivatives on the phenyl ring of the parent chroman of tocopherols compound or its analogue.Experiment shows, the water-soluble obvious enhancing of this analog derivative.In addition, because pyranoglucose is to be substituted on the phenyl ring but not on the phenolic hydroxyl group, therefore to have kept the anti-oxidant activity of this analog derivative preferably.
The said benzo-dihydropyran glycoside derivatives of the present invention has following structure:
In the formula: R
1, R
3Be selected from H respectively, CH
3With
In a kind of; R
2Be C
1-C
16Alkyl; R
4Be H or CH
3
In the present invention, preferred R
2Be C
1-C
16Chain (straight chain or have side chain) alkyl; Best R
2Be CH
3Or
The preparation method of the said benzo-dihydropyran glycoside derivatives of the present invention is: with corresponding Resorcinol (quinhydrones) or corresponding phenol is starting raw material; successively through methylate (for phenyl ring), 1; 2; 3; 4,6-five-O-ethanoyl-β-D-pyranoglucose after to replacement, benzoquinonesization, quinhydronesization, cyclisation and the alcoholysis of phenyl ring target compound.As with 2,3-dimethyl hydroquinone or 2,6-xylenol are that the preparation method of starting raw material comprises the steps:
(1) 1,4-is to methoxyl group-2, and 3-dimethyl benzene and 1,4-be to methoxyl group-2,6-dimethyl benzene synthetic:
A) 1,4-is to methoxyl group-2,3-dimethyl benzene synthetic:
With 2, the 3-dimethyl hydroquinone is dissolved in the dimethyl sulfoxide (DMSO), stir to add methyl iodide and potassium hydroxide solid down, and room temperature reaction 4~5 hours, reaction product obtains 1 behind extraction, washing, drying and column chromatography, and 4-is to methoxyl group-2,3-dimethyl benzene (white crystals); Reaction formula is:
Wherein, 2, the mol ratio of 3-dimethyl hydroquinone, methyl iodide, potassium hydroxide is 1: (3~5): (2~4).
B) 1,4-is to methoxyl group-2,6-dimethyl benzene synthetic:
With freshly prepd Fermi's salt (Fremy ' s salt) 0 ℃ soluble in water down, in this aqueous solution, add 2, the methanol solution of 6-xylenol.Reacted under the room temperature 6~8 hours, reaction product obtains yellow crystal 2,6-phlorone after extraction, washing, drying.With obtain 2, the 6-phlorone is dissolved in the chloroform, the powder that takes a policy (Sodium Hydrosulphite, Na
2S
2O
4) the aqueous solution, vigorous stirring is 10~20 minutes under the room temperature, reaction product is removed chloroform through concentrating, and obtains white solid 2 after extracted with diethyl ether, washing, drying, the 6-dimethyl hydroquinone.With 2, the 6-dimethyl hydroquinone is dissolved in the dimethyl sulfoxide (DMSO) again, and adds methyl iodide and potassium hydroxide solid, room temperature reaction 4~5 hours, reaction product behind extraction, washing, drying and column chromatography 1,4-is to methoxyl group-2,6-dimethyl benzene (light yellow oil liquid); Its reaction formula is as follows:
Wherein, 2,6-phlorone, Na
2S
2O
4Mol ratio be 1: (2~5), 2, the mol ratio of 6-dimethyl hydroquinone, methyl iodide, potassium hydroxide is: 1: (3~5): (2~4).
(2) 1-(2,3,4,6-four-O-ethanoyl-β-D-pyranoglucose)-2,5-dimethoxy-3,4-dimethyl benzene and 1-(2,3,4,6-four-O-ethanoyl-β-D-pyranoglucose)-2,4-dimethyl-3,6-dimethoxy benzene synthetic:
With 1,2,3,4,6-five-O-ethanoyl-β-D-pyranoglucose respectively with by institute's synthetic 1 in the step (1), 4-is to methoxyl group-2,3-dimethyl benzene and 1,4-are to methoxyl group-2, the 6-dimethyl benzene is dissolved in CH
2Cl
2In, stir and drop into catalyzer trifluoroacetic acid silver (AgOTfa) down earlier, add SnCl again
4CH
2Cl
2Solution.System's lucifuge; charge into argon shield; reaction is 2-4 hour under 20-30 ℃ condition; reaction product is through extraction with after column chromatography for separation removes inorganics and other organic by-products; in mixed solvent, carry out recrystallization; get 1-(2,3,4 respectively; 6-four-O-ethanoyl-β-D-pyranoglucose)-2; 5-dimethoxy-3,4-dimethyl benzene (white crystal) and 1-(2,3; 4; 6-four-O-ethanoyl-β-D-pyranoglucose)-2,4-dimethyl-3,6-dimethoxy benzene (white foam): its reaction formula is as follows:
Wherein, 1,2,3,4,6-five-O-ethanoyl-β-D-pyranoglucose and 1,4-be to methoxyl group-2, and 3-dimethyl benzene or 1,4-be to methoxyl group-2,6-dimethyl benzene, AgOTfa and SnCl
4Mol ratio be 1: (1.5-2): (1.0-1.6): (1.5-2.4); Temperature of reaction is 20-30 ℃; The used mixed solvent of recrystallization is ether and sherwood oil mixture, and its volume ratio is 1: 2.
(3) 5-(2,3,4,6-four-O-ethanoyl-β-D-pyranoglucose)-2,3-dimethyl-1,4-benzoquinones and 2-(2,3,4,6-four-O-ethanoyl-β-D-pyranoglucose)-3,5-dimethyl-1,4-benzoquinones synthetic:
Will be by the synthetic 1-of institute (2 in the step (2); 3,4,6-four-O-ethanoyl-β-D-pyranoglucose)-2; 5-dimethoxy-3; 4-dimethyl benzene and 1-(2,3,4; 6-four-O-ethanoyl-β-D-pyranoglucose)-2; 4-dimethyl-3,6-dimethoxy benzene are dissolved in respectively in the acetonitrile, drip cerous ammonium nitrate ((NH under the room temperature
4)
2Ce (NO
3)
6, stirred 20-40 minute, obtain 5-(2,3,4,6-four-O-ethanoyl-β-D-pyranoglucose)-2 respectively, 3-dimethyl-1,4-benzoquinones and 2-(2,3,4,6-four-O-ethanoyl-β-D-pyranoglucose)-3,5-dimethyl-1,4-benzoquinones.Reaction formula is as follows:
Wherein, 1-(2,3,4,6-four-O-ethanoyl-β-D-pyranoglucose)-2,5-dimethoxy-3,4-dimethyl benzene or 1-(2,3,4,6-four-O-ethanoyl-β-D-pyranoglucose)-2,4-dimethyl-3, the mol ratio of 6-dimethoxy benzene and cerous ammonium nitrate is 1: (3-5);
(4) 5-(2,3,4,6-four-O-ethanoyl-β-D-pyranoglucose)-2,3-dimethyl hydroquinone and 2-(2,3,4,6-four-O-ethanoyl-β-D-pyranoglucose)-3,5-dimethyl hydroquinone synthetic:
Will be by the synthetic 5-of institute (2,3,4,6-four-O-ethanoyl-β-D-pyranoglucose)-2 in the step (3); 3-dimethyl-1,4-benzoquinones and 2-(2,3,4; 6-four-O-ethanoyl-β-D-pyranoglucose)-3,5-dimethyl-1,4-benzoquinones are dissolved in respectively in the chloroform, add Sodium Hydrosulphite (Na under the room temperature
2S
2O
4) the aqueous solution, stirred 5-15 minute, reaction product is separated with column chromatography through extraction and is obtained 5-(2,3 respectively after removing inorganics, 4,6-four-O-ethanoyl-β-D-pyranoglucose)-2,3-dimethyl hydroquinone and 2-(2,3,4,6-four-O-ethanoyl-β-D-pyranoglucose)-3, the 5-dimethyl hydroquinone;
Wherein, 5-(2,3,4,6-four-O-ethanoyl-β-D-pyranoglucose)-2,3-dimethyl-1,4-benzoquinones or 2-(2,3,4,6-four-O-ethanoyl-β-D-pyranoglucose)-3,5-dimethyl-1,4-benzoquinones and Na
2S
2O
4Mol ratio be 1: (3-6); Its reaction formula is as follows:
(5) 5-(2,3,4,6-four-O-ethanoyl-β-D-pyranoglucose)-γ-vitamin-E and 8-(2,3,4,6-four-O-ethanoyl-β-D-pyranoglucose)-ε-vitamin-E is synthetic:
With the synthetic 5-of institute (2 in the step (4); 3,4,6-four-O-ethanoyl-β-D-pyranoglucose)-2; 3-dimethyl hydroquinone and 2-(2; 3,4,6-four-O-ethanoyl-β-D-pyranoglucose)-3; the 5-dimethyl hydroquinone is dissolved in the chloroform respectively; add phytol and Zinc Chloride Anhydrous, lucifuge, under argon shield backflow 24-30 hour.Reaction finishes after-filtration, filtrate through salt wash, wash, drying and column chromatography obtain 5-(2 respectively after removing other by product and inorganics, 3,4,6-four-O-ethanoyl-β-D-pyranoglucose)-γ-vitamin-E (white crystals) and 8-(2,3,4,6-four-O-ethanoyl-β-D-pyranoglucose)-ε-vitamin-E (faint yellow slurries);
Wherein, 5-(2,3,4,6-four-O-ethanoyl-β-D-pyranoglucose)-2,3-dimethyl hydroquinone or 2-(2,3,4,6-four-O-ethanoyl-β-D-pyranoglucose)-3,5-dimethyl hydroquinone and phytol and anhydrous ZnCl
2Mol ratio be 1: (0.8-2): (3-6); Its reaction formula is as follows:
(6) 5-(β-D-pyranoglucose)-γ-vitamin-E (compound 1) and 8-(β-D-pyranoglucose)-ε-vitamin-E (compound 2) is synthetic:
With step (5) the synthetic 5-of institute (2; 3; 4; 6-four-O-ethanoyl-β-D-pyranoglucose)-γ-vitamin-E and 8-(2; 3,4,6-four-O-ethanoyl-β-D-pyranoglucose)-ε-vitamin-E adds in the methanol solution of sodium methylate under argon shield respectively; stirred 2-3 hour under the room temperature, add excessive acidic cation-exchange resin IR-120
+Neutralization reaction liquid filters, and filtrate decompression concentrates through the column chromatography purification and obtains target compound (compound 1 and compound 2) respectively,
Wherein, the mol ratio of 5-(2,3,4,6-four-O-ethanoyl-β-D-pyranoglucose)-γ-vitamin-E or 8-(2,3,4,6-four-O-ethanoyl-β-D-pyranoglucose)-ε-vitamin-E and sodium methylate is (2-4): 1; Its reaction formula is as follows:
Compound 1
Compound 2
(7) 5-(2,3,4,6-four-O-ethanoyl-β-D-pyranoglucose)-6-hydroxyl-2,2,7,8-tetramethyl-benzo dihydropyrane and 8-(2,3,4,6-four-O-ethanoyl-β-D-pyranoglucose)-6-hydroxyl-2,2,5,7-tetramethyl-benzo dihydropyrane synthetic:
Will be by the synthetic 5-of institute (2 in the step (4); 3,4,6-four-O-ethanoyl-β-D-pyranoglucose)-2; 3-dimethyl hydroquinone and 2-(2; 3,4,6-four-O-ethanoyl-β-D-pyranoglucose)-3; the 5-dimethyl hydroquinone is dissolved in the chloroform respectively; add the pure and mild Zinc Chloride Anhydrous of 3-methyl-2-butene-1-then, lucifuge, under argon shield backflow 24-30 hour.Reaction finishes after-filtration, and filtrate is washed, washed, after drying and column chromatography remove other by product, obtains 5-(2 respectively through salt, 3,4,6-four-O-ethanoyl-β-D-pyranoglucose)-6-hydroxyl-2,2,7,8-tetramethyl-benzo dihydropyrane (white crystal) and 8-(2,3,4,6-four-O-ethanoyl-β-D-pyranoglucose)-6-hydroxyl-2,2,5,7-tetramethyl-benzo dihydropyrane (faint yellow slurries);
Wherein, 5-(2,3,4,6-four-O-ethanoyl-β-D-pyranoglucose)-2,3-dimethyl hydroquinone or 2-(2,3,4,6-four-O-ethanoyl-β-D-pyranoglucose)-3,5-dimethyl hydroquinone and the pure and mild ZnCl of 3-methyl-2-butene-1-
2Mol ratio be 1: (0.8-2): (3-6); Its reaction formula is as follows:
(8) 5-(β-D-pyranoglucose)-6-hydroxyl-2,2,7,8-tetramethyl-benzo dihydropyrane (compound 3) and 8-(β-D-pyranoglucose)-6-hydroxyl-2,2,5,7-tetramethyl-benzo dihydropyrane (compound 4) synthetic:
With step (7) the synthetic 5-of institute (2,3,4; 6-four-O-ethanoyl-β-D-pyranoglucose)-and 6-hydroxyl-2,2,7; 8-tetramethyl-benzo dihydropyrane and 8-(2,3,4; 6-four-O-ethanoyl-β-D-pyranoglucose)-6-hydroxyl-2; 2,5,7-tetramethyl-benzo dihydropyrane adds in the methanol solution of sodium methylate under argon shield respectively; stirred 2-3 hour under the room temperature, add excessive acidic cation-exchange resin IR-120 again
+Neutralization reaction liquid, filter, filtrate decompression concentrates and obtains target compound (compound 3 and compound 4) respectively through the column chromatography purification is 5-(β-D-pyranoglucose)-6-hydroxyl-2,2,7,8-tetramethyl-benzo dihydropyrane (compound 3) and 8-(β-D-pyranoglucose)-6-hydroxyl-2,2,5,7-tetramethyl-benzo dihydropyrane (compound 4);
Wherein, 5-(2,3,4,6-four-O-ethanoyl-β-D-pyranoglucose)-6-hydroxyl-2,2,7,8-tetramethyl-benzo dihydropyrane or 8-(2,3,4,6-four-O-ethanoyl-β-D-pyranoglucose)-6-hydroxyl-2,2,5, the mol ratio of 7-tetramethyl-benzo dihydropyrane and sodium methylate is (2-4): 1; Reaction formula is as follows:
Compound 4
Said other compound of the present invention can adopt method preparation similar to the above, and used reagent is commercially available product in the starting raw material that relates in described preparation method and each the step reaction.
The present invention successfully introduces pyranoglucose by rational synthesis step on the phenyl ring of parent chroman of tocopherols compound or its analogue, keeping under chroman derivatives (tocopherols compound or its analogue) the anti-oxidant activity prerequisite, improving that it is water-soluble.For the Application Areas of widening vitamin-E or its analogue is laid a good foundation.
Embodiment
The invention will be further elaborated by the following examples, and its purpose only is better to understand content of the present invention and unrestricted protection scope of the present invention:
Embodiment 1
Synthesizing of compound 1 and compound 3:
(1) 1,4-is to methoxyl group-2,3-dimethyl benzene synthetic:
With 2, (1.38g 0.01mol) is dissolved in the 8mL dimethyl sulfoxide (DMSO) (DMSO) the 3-dimethyl hydroquinone, stir add down methyl iodide (3.2mL, 7.3g, 0.05mol) and KOH (4g, 0.07mol) solid, room temperature reaction 5 hours, thin plate chromatography (TLC) show that reaction finishes.Add water 20mL and stirred 5 minutes, use CH again
2Cl
2Extract repeatedly, the combined dichloromethane extraction liquid is successively used saturated Na
2S
2O
3Saturated solution and saturated common salt water washing, anhydrous magnesium sulfate drying.Filter, organic phase decompression rotary evaporation removes and desolvates, and enriched material separates through a short column, with sherwood oil and CH
2Cl
2Mixed solvent (volume ratio is 2: 1) carry out wash-out, elutriant obtains white crystals 1 after solvent removed by evaporation at reduced pressure, 4-is to methoxyl group-2, the 3-dimethyl benzene;
(2) 1-(2,3,4,6-four-O-ethanoyl-β-D-pyranoglucose)-2,5-dimethoxy-3,4-dimethyl benzene synthetic:
With 1,2,3,4, and 6-five-O-ethanoyl-β-D-pyranoglucose (985mg, 2.5mmol) and step (1) institute synthetic 1,4-is to methoxyl group-2, and (830mg, 5.0mmol 2eq) are dissolved in 12mLCH to the 3-dimethyl benzene
2Cl
2In, 25 ℃ condition stirred for several minute, treat that raw material dissolves fully after, (3.75mmol, 1.5eq), shading keeps 25 ℃ of system temperatures, slowly drips 1MSnCl under protection of inert gas to add catalyzer trifluoroacetic acid silver (AgOTfa) 831mg
4CH
2Cl
2Solution 7.5ml (7.5mmol, 3eq).Stirring reaction, thin plate chromatography (TLC) shows that reaction finishes, and adds saturated NaHCO after 4 hours
3Aqueous solution 40mL stirred 20 minutes, and suction filtration is removed inorganics, filtrate with dichloromethane extraction repeatedly, the combined dichloromethane extraction liquid is with saturated common salt solution washing, anhydrous magnesium sulfate drying.Filter; organic phase decompression rotary evaporation removes and desolvates; laboratory chromatography column commonly used separates on the enriched material, carries out wash-out with the mixed solvent (volume ratio is 2: 1) of sherwood oil and ethyl acetate, and elutriant is after solvent removed by evaporation at reduced pressure; obtain 1-(2; 3,4,6-four-O-ethanoyl-β-D-pyranoglucose)-2; 5-dimethoxy-3, the 4-dimethyl benzene.Recrystallization gets white crystals 825mg with the mixed solvent of ether and sherwood oil, and productive rate 66.5% is stand-by.
The product test result is:
White crystal, mp89.5-91 ℃ (ether/sherwood oil); (developping agent is sherwood oil and ethyl acetate=1: 2 to Rf=0.43, v/v); [α]
D 22=-20.8 (c=0.76, methylene dichloride);
1H-NMR(CDCl
3,200MHz):6.71(s,1H,Ar-H),5.52(t,1H,J=9.1,9.9Hz,H
2’),5.38(t,1H,J=9.1Hz,H
3’),5.24(t,1H,J=9.1,9.7Hz,H
4’),4.90(d,1H,J=10Hz,H
1’),4.24(dd,1H,J=12.3,5.0Hz,H
6a’),4.12(dd,1H,J=12.3,2.3Hz,H
6b’),3.90(ddd,1H,J=2.3,5.0,9.7Hz,H
5’),3.81(s,3H,OMe),3.72(s,3H,OMe),2.21,2.12,2.07,2.04,2.03,1.80(6s,18H,CH
3).
13C-NMR (CDCl
3, 50MHz): 170.7,170.4,169.6,169.3 (C=O, ethanoyl), 154.0,151.2 (C
1, C
4), 131.0,128.1,125.3 (C
2, C
5, C
6), 106.6 (C
3), 76.2,74.9,74.5,70.8,68.9 (C
1 ', C
2 ', C
3 ', C
4 ', C
5 '), 62.7 (C
6 '), 62.0,55.8 (OCH
3), 20.8,20.7,20.7,20.6 (CH
3, ethanoyl), 12.8,12.2 (CH
3, Ar).
Ultimate analysis (C
24H
32O
11): theoretical value: C, 58.06; H, 6.50; O, 35.45. actual value: C, 57.94; H, 6.62; O, 34.90.
(3) 5-(2,3,4,6-four-O-ethanoyl-β-D-pyranoglucose)-2,3-dimethyl-1,4-benzoquinones synthetic:
With step (2) the synthetic 1-of institute (2; 3,4,6-four-O-ethanoyl-β-D-pyranoglucose)-2; 5-dimethoxy-3; (1120mg 2.26mmol) is dissolved in the 4mL acetonitrile 4-dimethyl benzene, drips cerous ammonium nitrate (3717mg under the room temperature; 6.78mmol; aqueous solution 5mL 3eq) stirred 25 minutes, and TLC shows that reaction finishes.Reaction solution dichloromethane extraction, organic phase saturated common salt solution washing, anhydrous magnesium sulfate drying.Filter, the liquid residue underpressure distillation removes and desolvates, and gets 5-(2,3,4,6-four-O-ethanoyl-β-D-pyranoglucose)-2,3-dimethyl-1,4-benzoquinones 1028mg, productive rate 97.6%.
The product test result is as follows:
Yellow needle-like crystal, mp119-120 ℃ (methylene dichloride/sherwood oil); Rf=0.45 (developping agent is a sherwood oil: ethyl acetate=2: 1, v/v); [α]
D 25=-1.2 (c=0.8, methylene dichloride); IR (KBr): 1760 (C=O, ethanoyl), 1650 (C=O, benzoquinones);
1H-NMR(CDCl
3,200MHz):6.80(d,1H,J=0.8Hz,Ar),5.34(t,1H,J=9.2,9.4Hz,H
3’),5.11(t,1H,J=9.4,10.0Hz,H
4’),4.97(t,1H,J=9.2,9.7Hz,H
2’),4.66(dd,1H,J=9.7,0.8Hz,H
1’),4.20(dd,1H,J=4.7,12.4Hz,H
6a’),4.10(dd,1H,J=2.3,12.4Hz,H
6b’),3.79(ddd,1H,H
5’),2.06,2.02,1.99,1.99,1.98,1.87(6s,18H,CH
3).
13C-NMR (CDCl
3, 50MHz): 186.9,185.7 (C=O, benzoquinones), 170.6,170.1,169.7,169.5 (C=O, ethanoyl), 143.4,141.0,140.9 (C
2, C
5, C
6), 133.4 (C
3), 76.2,73.8,72.3,72.2,68.3 (C
1 ', C
2 ', C
3 ', C
4 ', C
5 '), 62.0 (C
6 '), 20.8,20.6,20.6,20.5 (CH
3, ethanoyl), 12.4,12.2 (benzoquinones-CH
3).
Ultimate analysis (C
22H
26O
11): theoretical value: C, 56.65; H, 5.62; O, 37.73. actual value: C, 56.56; H, 5.97; O, 36.77.
(4) 5-(2,3,4,6-four-O-ethanoyl-β-D-pyranoglucose)-2,3-dimethyl hydroquinone synthetic:
With step (3) the synthetic 5-of institute (2,3,4,6-four-O-ethanoyl-β-D-pyranoglucose)-2,3-dimethyl-1, (932mg 2mmol) is dissolved in the 6mL chloroform 4-benzoquinones, adds Na under the room temperature
2S
2O
4(2052mg, 12mmol, aqueous solution 7mL 6eq), vigorous stirring 10 minutes, TLC shows that reaction finishes.Isolate organic phase, water chloroform extraction 2 times merge organic phase, saturated common salt washing twice, anhydrous MgSO
4Dry 3-4 hour, to filter, filtrate decompression is spin-dried for solvent, and (eluent is a methylene dichloride to residue: ethyl acetate=8: 1 through column chromatography; v/v) obtain product 5-(2,3,4; 6-four-O-ethanoyl-β-D-pyranoglucose)-2,3-dimethyl hydroquinone 820mg (1.752mmol), productive rate 87.6%.
The product test result is as follows:
White crystal, mp:192-193 ℃ (methylene dichloride/sherwood oil); Rf=0.21 (developping agent is a methylene dichloride: ethyl acetate=8: 1, v/v); [α]
D 25=-37 (c=0.8, chloroforms);
1H-NMR(CDCl
3,200MHz):6.49(s,1H,OH,Ar),6.35(s,1H,Ar-H),5.37-5.23(m,3H,H
2’,H
3’,H
4’),4.87(s,1H,OH,Ar),4.52(br?d,1H,J=8.0Hz,H
1’),4.32(dd,1H,J=3.8Hz,12.4Hz,H
6a’),4.16(d,1H,J=12.4Hz,H
6b’),3.89(m,1H,H
5’),2.16,2.13,2.12,2.06,2.01,1.86(6s,18H,CH
3).
13C-NMR (CDCl
3, 50MHz): 170.8,170.5,169.5,169.0 (C=O, ethanoyl), 146.8,146.8 (C
1, C
4Ar), 126.6,125.1,117.6 (C
2, C
5, C
6, Ar), 111.7 (C
3, Ar), 80.0,76.1,73.9,70.7,68.0 (C
1 ', C
2 ', C
3 ', C
4 ', C
5 '), 61.7 (C
6 '), 20.7,20.7,20.6,20.5 (CH
3, ethanoyl), 12.2,12.1 (Ar-CH
3).
Ultimate analysis (C
22H
28O
11): theoretical value: C, 56.41; H, 6.02; O, 37.57. actual value: C, 56.15; H, 6.22; O, 37.26.
(5) 5-(2,3,4,6-four-O-ethanoyl-β-D-pyranoglucose)-γ-vitamin-E is synthetic:
With step (4) the synthetic 5-of institute (2; 3,4,6-four-O-ethanoyl-β-D-pyranoglucose)-2; 3-dimethyl hydroquinone (270mg; 0.577mmol) be dissolved in the 5mL chloroform, (0.556mmol is 0.96eq) with Zinc Chloride Anhydrous 453.7mg (3.336mmol to add phytol 0.2mL; 6eq); system's lucifuge refluxed 26 hours under argon shield, and TLC shows the basic end of reaction.Reaction mixture is filtered, and filtrate is earlier after NaHCO
3Saturated solution, saturated common salt washing, anhydrous MgSO
4Dry 3-4 hour.Filter, filtrate decompression is spin-dried for solvent, and (eluent is a sherwood oil to residue: ethyl acetate=3: 1 through column chromatography; v/v), promptly obtain product white crystals 5-(2,3; 4,6-four-O-ethanoyl-β-D-pyranoglucose)-γ-vitamin-E (formula 1) 272mg (0.365mmol), productive rate 65.6%.
The product test result is as follows:
White crystal, mp:144-146 ℃ (methylene dichloride/sherwood oil); Rf=0.20 (developping agent is a sherwood oil: ethyl acetate=3: 1, v/v); [α]
D 22=-0.227 (c=0.88, methylene dichloride);
1H-NMR (CDCl
3, 200MHz): 6.93,6.90 (2s, 1H, Ar-OH), 5.58 (t, 1H, J=7.9,9.9Hz, H
2 "), 5.35-5.30 (m, 2H, H
3 ", H
4 "), 4.86 (d, 1H, J=9.9Hz, H
1 "), 4.33 (dd, 1H, J=2.9,12.4Hz, H
6a "), 4.15 (d, 1H, J=12.4Hz, H
6b "), 3.89 (m, 1H, H
5 "), 2.70 (t, 2H, J=6.5Hz, H
4a, b), 2.14,2.14,2.08,2.06,2.01,1.82 (6s, 18H, CH
3), 1.75 (2H is capped, H
3a, b), 1.60-1.0 (m, 24H, H
1 '-12 ', H
2a), 0.89-0.86 (m, 12H, Me
13 ' 4 ' a, 8 ' a, 12 ' a).
13C-NMR (CDCl
3, 50MHz): 170.7,170.5,169.3,168.4 (C=O, ethanoyl), 146.8,144.9 (C
6, C
8a), 127.6,124.9,115.6,114.9 (C
5, C
7, C
8, C
4a), 76.2,76.2,74.2,70.3,67.8 (C
1 ", C
2 ", C
3 ", C
4 ", C
5 "), 74.4 (C
2), 61.4 (C
6 "), 39.4,39.4,37.4,37.4,37.3,31.7,24.8,24.5,21.0,20.6,20.6 (methylene radical: C
3, C
4, C
1 ', C
2 ', C
3 ', C
5 ', C
6 ', C
7 ', C
9 ', C
10 ', C
11 ', 32.8,28.0,23.5,22.8,22.6,20.4,19.8,19.7 (C
4 ', C
8 ', C
12 ', C
13 ', C
4 ' a, C
8 ' a, C
12 ' a, C
2a), 20.7,20.7,20.6,20.6 (CH
3, ethanoyl), 12.2,11.9 (C
7a, C
8b).
Ultimate analysis (C
42H
66O
11): theoretical value: C, 67.53; H, 8.91; O, 23.56. actual value: C, 67.56; H, 8.83; O, 22.67.
(6) synthetic (compound 1) of 5-(β-D-pyranoglucose)-γ-vitamin-E:
With step (5) the synthetic 5-of institute (2; 3; 4; 6-four-O-ethanoyl-β-D-pyranoglucose)-γ-vitamin-E (405mg; 0.54mmol) under argon shield, add among methanol solution (0.1M) 5mL of sodium methylate; stirred 3 hours under the room temperature, add excessive a little acidic cation-exchange resin IR-120
+Neutralization reaction liquid, stir after 5 minutes, filter, filtrate decompression concentrates, (proportioning of eluent is followed successively by residue: ethyl acetate: methylene dichloride=2: 1 with linear gradient elution method through column chromatography, 4: 1,8: 1, v/v is pure ethyl acetate at last) obtain three portion of product (chiral isomer), promptly (β-D-pyranoglucose)-γ-vitamin-E (2S) is (70.4mg) for 5-, 5-(β-D-pyranoglucose)-γ-vitamin-E (2S, 2R) (125.5mg), 5-(β-D-pyranoglucose)-γ-vitamin-E (2R) (100.6mg), overall yield 95%.
The solvability of compound 1 is: being slightly soluble in water, very easily being dissolved in acetone, methyl alcohol, pyridine, DMSO, is moderate solubility in chloroform.Its test result is as follows:
5-(β-D-pyranoglucose)-γ-vitamin-E (2S): light yellow solid, [α]
D 22=+28.5 (c=1, acetone); Rf=0.50 (developping agent is a pure ethyl acetate);
1H-NMR (acetone-d
6, 500MHz): 7.76 (s, 1H, Ar-OH), 4.73 (d, 1H, J=9.5Hz, H
1 "), 4.72,4.47,4.26,3.13 (4 br signals, 4H, sugar-OH), 3.90-3.83 (m, 2H, H
6a ", H
6b "), 3.77 (t, 1H, J=9.5,8.8Hz, H
2 "), 3.71 (t, 1H, J=8.8,9.2Hz, H
4 "), 3.60 (t, 1H, J
3,4=8.8Hz, H
3 "), 3.49 (br d, 1H, J=9.2Hz, H
5 "), 3.00 (m, 1H, H
4a), 2.64 (m, 1 H, H
4b), 2.07,2.07 (2s, 6H, Me
7a, Me
8b), 1.75 (m, 2H, H
3a, b), 1.59-1.13 (m, 21H, H
1 '-12 '), 1.22 (s, 3H, H
2a), 0.91-0.89 (m, 12H, H
13 ', H
4 ' a, H
8 ' a, H
12 ' a).
13C-NMR (acetone-d
6, 125MHz): 147.2 (C
6), 144.8 (C
8a), 125.1 (C
8), 123.1 (C
7), 119.0 (C
5), 117.7 (C
4a), 81.3 (C
5 "), 78.8 (C
3 "), 78.3 (C
1 "), 74.5 (C
2), 73.3 (C
2 "), 70.0 (C
4 "), 61.2 (C
6 "), 31.9,31.8 (C
3), 20.7 (C
4), 40.3,40.1,39.6,38.0,37.9,37.9,37.9,37.7,37.7,37.6,25.1,24.7,21.4,21.3,20.7 (C
1 ', C
2 ', C
3 ', C
5 ', C
6 ', C
7 ', C
9 ', C
10 ', C
11 '), 33.1,33.0,32.9,28.2,23.6,22.6,22.5,19.7,19.7,19.6,19.5 (C
4 ', C
8 ', C
12 ', C
13 ', C
4 ' a, C
8 ' a, C
12 ' a, C
2a), 11.8,11.6 (C
7a, C
8b).
MS(ESI+C):m/z1179.3[2M+Na]
+(100%),578.3[M]
+(30%).
(ESI-C):m/z1190.8[2M+Cl]
-(40%),613.2[M+Cl]
-(100%),577.2[M-H]
-(20%).
5-(β-D-pyranoglucose)-γ-vitamin-E (2R): light yellow solid, [α]
D 22=+42.4 (c=1, acetone); Rf=0.43 (developping agent is a pure ethyl acetate);
1H-NMR (acetone-d
6, 500MHz): 7.79 (s, 1H, Ar-OH), 4.73 (d, 1H, J=9.5Hz, H
1 "), 4.62,4.47,4.19,3.01 (4s, 4H, sugar-OH), 3.89-3.83 (m, 2H, H
6a ", H
6b "), 3.75 (t, 1H, J=9.5,8.8Hz, H
2 "), 3.70 (t, 1H, J=8.8,9.8Hz, H
4 "), 3.58 (t, 1H, J=8.8Hz, H
3 "), 3.49 (dt, 1H, J=9.5Hz, H
5 "), 2.96 (m, 1H, H
4a), 2.68 (dt, 1H, J=6.3,6.6Hz, J
Gem=16.4H
4b), 2.07,2.07 (s, 6H, Me
7a, Me
8b), 1.74 (t, 2H, J=6.6Hz, H
3a, b), 1.62-1.11 (m, 21H, H
1 '-12 '), 1.22 (s, 3H, H
2a), 0.90-0.88 (m, 12H, H
13 ', H
4 ' a, H
8 ' a, H
12 ' a).
13C-NMR (acetone-d
6, 50MHz): 148.2 (C
6), 145.9 (C
8a), 126.2 (C
8), 124.2 (C
7), 120.2 (C
5), 118.8 (C
4a), 82.5 (C
5 "), 80.0 (C
3 "), 79.5 (C
1 "), 75.6 (C
2), 74.5 (C
2 "), 71.3 (C
4 "), 62.4 (C
6 "), 33.1 (C
3), 21.9 (C
4), 41.4,40.7,39.1,38.8,38.6,26.2,26.2,25.8,22.4 (C
1 ', C
2 ', C
3 ', C
5 ', C
6 ', C
7 ', C
9 ', C
10 ', C
11 '), 33.0,32.9,28.2,23.6,22.6,22.5,19.7,19.6 (C
4 ', C
8 ', C
12 ', C
13 ', C
4 ' a, C
8 ' a, C
12 ' a, C
2a), 11.8,11.6 (Me
7a, Me
8b).
MS(ESI+C):m/z1179.3[2M+Na]
+(65%),578.3[M]
+(100%).
(ESI-C):m/z1190.9[2M+Cl]
-(65%),613.2[M+Cl]
-(100%),577.3[M-H]
-(65%).
(7) 5-(2,3,4,6-four-O-ethanoyl-β-D-pyranoglucose)-6-hydroxyl-2,2,7,8-tetramethyl-benzo dihydropyrane synthetic:
With step (4) the synthetic 5-of institute (2; 3; 4,6-four-O-ethanoyl-β-D-pyranoglucose)-2,3-dimethyl hydroquinone (560mg; 1.2mmol) be dissolved in the 5mL chloroform; adding 3-methyl-2-butene-1-alcohol 0.123mL (1.19mmol) and Zinc Chloride Anhydrous 979mg (7.2mmol, 6eq), system's lucifuge; refluxed 26 hours under argon shield, TLC shows the basic end of reaction.Reaction mixture is filtered, and filtrate is earlier after NaHCO
3Saturated solution, saturated common salt washing, anhydrous MgSO
4Dry 3-4 hour.Filter; filtrate decompression is spin-dried for solvent, residue through column chromatography (eluent is a sherwood oil: ethyl acetate=2: 1, v/v); promptly obtain product 5-(2; 3,4,6-four-O-ethanoyl-β-D-pyranoglucose)-6-hydroxyl-2; 2; 7,8-tetramethyl-benzo dihydropyrane (white crystals) 384mg (0.716mmol), productive rate 60%.
The test result of product is:
White crystals, mp:205-206.5 ℃ (methylene dichloride/sherwood oil); Rf=0.23 (developping agent is a sherwood oil: ethyl acetate=2: 1, v/v); [α]
D 22=-4.4 (c=0.9, methylene dichloride).
1H-NMR (CDCl
3, 200MHz): 6.93 (s, 1H, Ar-OH), 5.58 (t, 1H, J=9.3,10.0Hz, H
2 '), 5.35-5.31 (m, 2H, H
3 ', H
4 '), 4.86 (d, 1H, J=10.0Hz, H
1 '), 4.33 (dd, 1H, J=3.14Hz, 12.5Hz, H
6a '), 4.14 (dd, 1H, J=2.0,12.5Hz, H
6b '), 3.86 (m, 1H, H
5 '), 2.72 (t, 2H, J=6.7Hz, 2H
4), 2.14,2.14 2.07,2.06,2.01,1.81 (6s, 18H, 4OAc, Me
7a, Me
8b), 1.75 (2H is capped, 2H
3), 1.29,1.23 (2s, 6H, Me
2a, Me
2b).
13C-NMR (CDCl
3, 50.32 MHz): 170.7,170.5,169.3,168.4 (C=O, ethanoyl), 146.9,145.0 (C
6, C
8a, Ar), 127.6,124.9,115.4,114.9 (C
5, C
7, C
8, C
4a, Ar), 76.2,76.2,74.2,70.3,67.7 (C
1 ', C
2 ', C
3 ', C
4 ', C
5 '), 72.4 (C
2), 61.4 (C
6 '), 33.1,20.8 (C
3, C
4), 26.9,26.3 (C
2a, C
2b), 20.7,20.7,20.6,20.4 (CH
3, ethanoyl), 12.2,11.9 (Me
7a, Me
8b).
Ultimate analysis (C
27H
36O
11): theoretical value: C, 60.44; H, 6.76; O, 32.80. actual value: C, 59.98; H, 6.74; O, 33.75.
(8) 5-(β-D-pyranoglucose)-6-hydroxyl-2,2,7, synthetic (compound 3) of 8-tetramethyl-benzo dihydropyrane:
With step (7) the synthetic 5-of institute (2; 3; 4; 6-four-O-ethanoyl-β-D-pyranoglucose)-and 6-hydroxyl-2,2,7; 8-tetramethyl-benzo dihydropyrane (268mg; 0.5mmol) under argon shield, add among methanol solution (0.1M) 4mL of sodium methylate, stirred 3 hours under the room temperature, add excessive a little acidic cation-exchange resin IR-120
+Neutralization reaction liquid stirred after 5 minutes, filtered, and filtrate decompression concentrates, and residue obtains 168.4mg white solid product (being compound 3), productive rate 91.5% through column chromatography (eluent is a pure ethyl acetate).
The solvability of compound 3 is, and is water-soluble, very easily is dissolved in acetone, methyl alcohol, pyridine, DMSO, is slightly soluble in chloroform.Its structured testing result is:
White solid, mp135-137 ℃ (ethylacetate/ether); Rf=0.23 (developping agent is a pure ethyl acetate); [α]
D 22=+48.2 (c=0.7, acetone);
1H-NMR (acetone-d
6, 500MHz): 7.75 (s, 1H, Ar-OH), 4.74 (d, 1H, J=9.5Hz, H
1 '), 4.43,4.39,4.09 (3br signals, 3H, sugar-OH), 3.90-3.84 (m, 2H, H
6a ', H
6b '), 3.76 (t, 1H, J=9.5,9.1Hz, H
2 '), 3.69 (t, 1H, J=9.1,9.5Hz, H
4 '), 3.58 (t, 1H, J=9.1,8.8Hz, H
3 '), 3.50 (dt, 1H, J=9.5,3.1Hz, H
5 '), 2.98 (m, 2H are capped, sugar-OH, H
4a), 2.68 (dt, 1H, J
Gem=16.4Hz, J=6.6Hz, H
4b), 2.07,2.05 (2s, 6H, Me
7a, Me
8b), 1.74 (m, 2H, H
3a, b), 1.28,1.25 (2s, 6H, Me
2a, Me
2b).
13C-NMR (acetone-d
6, 125MHz): 147.3 (C
6), 145.0 (C
8a), 125.1 (C
8), 123.1 (C
7), 119.0 (C
5), 117.5 (C
4a), 81.3 (C
5 '), 79.0 (C
3 '), 78.4 (C
1 '), 73.4 (C
2 '), 72.5 (C
2), 70.2 (C
4 '), 61.3 (C
6 '), 33.3 (C
3), 26.8,26.2 (C
2a, C
2b),
*21.1 (C
4), 11.7,11.5 (C
7a, C
8b).
MS(ESI+C):m/z759.0[2M+Na]
+(100%),391.1[M+Na]
+(15%),369.0[M+H]
+(10%).
(ESI-C):m/z770.7[2M+Cl]
-(10%),402.8[M+Cl]
-(100%),367.0[M-H]
-(85%).
Embodiment 2
Synthesizing of compound 2 and compound 4:
(1) 1,4-is to methoxyl group-2,6-dimethyl benzene synthetic:
(34g 0.50mol) is dissolved under ice bath in the 100mL water, drops into the trash ice of 200g, stirs the two sodium sulfate (Na that lay particular stress on that drip 100mL down with Sodium Nitrite
2S
2O
5) the aqueous solution (35%, w/v), add the 20mL Glacial acetic acid then.Add 25mL strong aqua (sp gr0.8) after 3 minutes.(12.6g, aqueous solution 0.079mol) continue to stir 1 hour after-filtration, and the purple filtrate of gained is poured the saturated solution of the KCl in the 800mL stirring into to react the potassium permanganate that slowly drips 400mL after 30 minutes.Stir 1 hour after-filtration and promptly obtain Fermi's salt (Fremy ' s salt).Freshly prepared Fermi's salt is soluble in water under 0 ℃, stir down and slowly drip 2,6-xylenol (4.5g, methanol solution 400mL 0.037mol).Reaction afterreaction product dichloromethane extraction 3 times in 6-8 hour under the room temperature, the extraction liquid washing is again with obtaining yellow crystal 2 behind the anhydrous magnesium sulfate drying, 6-phlorone 4.2g, productive rate 83%.With obtain 2, the 6-phlorone is dissolved in the 10mL chloroform, adds Na
2S
2O
4(21.5g, aqueous solution 12mL 4eq), under the room temperature vigorous stirring 10-20 minute, reaction mixture is removed chloroform through underpressure distillation, adds extracted with diethyl ether repeatedly, and combined ether layer obtains white solid 2 behind washing, anhydrous magnesium sulfate drying, 6-dimethyl hydroquinone 4.0g, productive rate 93.8%.
All the other operations are identical with embodiment 1 corresponding part step (1), obtain light yellow liquid 1, and 4-is to methoxyl group-2, and 6-dimethyl benzene, productive rate are 73.9%.
(2) 1-(2,3,4,6-four-O-ethanoyl-β-D-pyranoglucose)-2,4-dimethyl-3,6-dimethoxy benzene synthetic:
Operation is identical with embodiment 1 corresponding part step (2), obtains 1-(2,3,4,6-four-O-ethanoyl-β-D-pyranoglucose)-2,4-dimethyl-3, and 6-dimethoxy benzene, productive rate are 73.9%.
The product test result is as follows:
White foam, [α]
D 22=-10.1 (c=0.86, methylene dichloride); (developping agent is sherwood oil and ethyl acetate=2: 1 to Rf=0.40, v/v);
1H-NMR(DMSO-d
6,300MHz,90℃):6.69(s,1H,Ar-H),5.54(t,1H,J=9.3Hz,H
2’),5.30(t,1H,J=9.5,9.3Hz,H
3’),5.10(d,1H,J=9.3?H
1’),5.05(t,1H,J=9.5,10.0Hz,H
4’),4.16(dd,1H,J=12.4,3.4Hz,H
6a’),4.11(dd,1H,J=12.4,4.1Hz,H
6b’),4.00(m,1H,H
5’),3.76(s,3H,OMe),3.58(s,3H,OMe),2.33,2.22,2.03,2.01,1.95,1.69(6s,18H,CH
3).
13C-NMR (DMSO-d
6, 75MHz, 90 ℃): 170.1,169.7,169.5,168.7 (C=O, ethanoyl), 154.6,151.3 (C
1, C
4), 131.8,131.7,121.7 (C
2, C
3, C
5), 112.9 (C
6), 75.4,74.7,73.6,70.6,69.2 (C
1 ', C
2 ', C
3 ', C
4 ', C
5 '), 62.5 (C
6 '), 59.8,56.9 (OCH
3), 20.6,20.6,20.5,20.2 (CH
3, ethanoyl), 16.4,12.5 (CH
3, Ar)
Ultimate analysis (C
24H
32O
11): theoretical value: C, 58.06; H, 6.50; O, 35.45. actual value: C, 57.76; H, 6.46; O, 35.95.
(3) 2-(2,3,4,6-four-O-ethanoyl-β-D-pyranoglucose)-3,5-dimethyl-1,4-benzoquinones synthetic:
Operation is identical with embodiment 1 corresponding part step (3), obtains 2-(2,3,4,6-four-O-ethanoyl-β-D-pyranoglucose)-3,5-dimethyl-1, and 4-benzoquinones, productive rate are 93.2%.
The product test result is as follows:
Yellow needle crystal, mp149-150.5 ℃ (methylene dichloride/sherwood oil); Rf=0.43, (developping agent is sherwood oil and ethyl acetate=1: 2, v/v); [α]
D 22=-63 (c=0.7, methylene dichloride); IR (KBr): 1750 (C=O, ethanoyl), 1650 (C=O, benzoquinones).
1H-NMR (500 MHz, CDCl
3): 6.56 (d, 1H, J=14Hz, Ar-H), 5.43 (t, 1H, J=9.1,9.9Hz, H
2 '), 5.31 (t, 1H, J=9.1,9.7Hz, H
3 '), 5.20 (t, 1H, J=9.7Hz, H
4 '), 4.96 (d, 1H, J=9.9Hz, H
1 '), 4.20 (dd, 1H, J=2.6,12.5Hz, H
6a '), 4.17 (dd, 1H, J=4.0,12.5Hz, H
6b '), 3.76 (dq, 1H, H
5 '), 2.27,2.08,2.06,2.01,1.87 (5s, 15H, ethanoyl and 3 methyl), 2.04 (d, 3H, J=1.5Hz, 5 methyl).
13C-NMR (CDCl
3, 50MHz): 187.7,185.3 (C=O, benzoquinones), 170.6,170.1,169.6,169.5 (C=O, ethanoyl), 145.9,145.8,136.8 (C
2, C
3, C
5), 133.0 (C
6), 76.3,74.2,71.9,70.2,68.3 (C
1 ', C
2 ', C
3 ', C
4 ', C
5 '), 61.9 (C
6 '), 20.7,20.6,20.6,20.4 (CH
3, ethanoyl), 16.0,12.7 (CH
3, benzoquinones)
Ultimate analysis (C
22H
26O
11): theoretical value: C, 56.65; H, 5.62; O, 37.73. actual value: C, 56.57; H, 5.61; O, 37.50.
(4) 2-(2,3,4,6-four-O-ethanoyl-β-D-pyranoglucose)-3,5-dimethyl hydroquinone synthetic:
Operation is identical with embodiment 1 corresponding part step (4), obtains 2-(2,3,4,6-four-O-ethanoyl-β-D-pyranoglucose)-3,5-dimethyl hydroquinone, productive rate 95%.
The product test result is as follows:
White crystal l, mp:198.5-200 ℃ (methylene dichloride/sherwood oil); Rf=0.17 (developping agent is a methylene dichloride: ethyl acetate=8: 1, v/v); [α]
D 25=-23.9 (c=0.8, methylene dichloride).
1H-NMR (CDCl
3, 500MHz): 6.95 (s, 1H, OH), 6.58 (s, 1H, H
6), 5.50 (t, 1H, J=9.5Hz, H
2 '), 5.37-5.30 (2 overlapping three peaks, 2H, H
3 ', H
4 '), 4.91 (d, 1H, J=9.9Hz, H
1 '), 4.32 (dd, 1H, J=2.3Hz, 12.5Hz, H
6a '), 4.25 (s, 1H, OH), 4.15 (dd, 1H, J=12.5,1.4Hz, H
6b '), 3.88 (m, 1H, H
5 '), 2.21,2.17,2.12,2.06,2.01,1.81 (6s, 18H, CH
3)
1H-NMR (CDCl
3, 200MHz): 6.96 (s, 1H, OH), 6.58 (s, 1H, H
6), 5.51 (m, 1H, H
2 '), 5.41-5.27 (m, 2H, H
3 ', H
4 '), 4.92 (d, 1H, J=9.8Hz, H
1 '), 4.33 (dd, 1H, J=3.0Hz, 12.5Hz, H
6a '), 4.2 (be capped, 1H, OH), 4.16 (dd, J=12.5,2.2Hz, H
6b '), 3.89 (m, 1H, H
5 '), 2.22,2.18,2.13,2.07,2.02,1.82 (6s, 18H, CH
3);
13C-NMR (CDCl
3, 50MHz): 170.7,170.4,169.4,168.6 (C=O, ethanoyl), 149.4,145.5 (C
1, C
4), 125.3,125.3,122.3 (C
2, C
3, C
5, Ar), 117.6 (C
6), 77.0,76.1,73.9,70.4,67.8 (C
1 ', C
2 ', C
3 ', C
4 ', C
5 '), 6 1.4 (C
6 '), 20.7,20.7,20.6,20.3 (CH
3, ethanoyl), 16.3,12.3 (Ar-CH
3).
Ultimate analysis (C
22H
28O
11): theoretical value: C, 56.41; H, 6.02; O, 37.57. actual value: C, 56.03; H, 6.21; O, 37.51.
(5) 8-(2,3,4,6-four-O-ethanoyl-β-D-pyranoglucose)-ε-vitamin-E is synthetic:
Operation is identical with embodiment 1 corresponding part step (5), obtains 8-(2,3,4,6-four-O-ethanoyl-β-D-pyranoglucose)-ε-vitamin-E, productive rate 62.7%.
The product test data is as follows:
The red-brown syrup, (developping agent is sherwood oil and ethyl acetate=3: 1 to Rf=0.26, v/v); [α]
D 25=+4.66 (c=0.88, methylene dichloride).
1H-NMR(DMSO-d
6,120℃,500MHz):7.26(s,1H,Ar-OH,at?90?C),5.64(br?signal,1H,H
2”),5.234,5.227(2t,1H,J=9.5,9.1Hz,H
3”),5.11(br?signal,1H,H
1”),5.10-5.04(m,1H,H
4”),4.16(dd,1H,J=3.2,12Hz,H
6”a),4.11(dd,1H,J=4.5,12Hz,H
6”b),3.86(m,1H,H
5”),2.57(m,2H,H
4a,H
4b),2.27,2.08,2.02,2.00,1.94(5s,15H,2-ArCH
3,3-OAc),1.74(m,2H,H
3a,H
3b),1.71(s,3H,C
2”-OAc),1.61-1.12(m,24H,H
1-12’,Me
2a),0.93-0.87(m,12H,Me
13’,4’a,8’a,12’a).
13C-NMR (DMSO-d
6, 120 ℃, 125MHz): 170.4,170.15,170.1,169.9,169.8,169.1 (C=O, ethanoyl), 146.5,125.3,125.3,125.2,125.1,120.4,120.2,118.5,118.4 (C
6, C
8a, C
5, C
7, C
8, C
4a), 76.3,76.0,71.6,70.2,70.1 (C
1 ", C
2 ", C
3 ", C
4 ", C
5 "), 75.7,75.6 (C
2), 63.5,63.4 (C
6 "), 41.5,39.8,38.2,37.8,37.7,37.6,31.9,24.9,24.7,21.5,21.1 (methylene radical: C
3, C
4, C
1 ', C
2 ', C
3 ', C
5 ', C
6 ', C
7 ', C
9 ', C
10 ', C
11 '), 33.1,28.2,24.0,23.7,23.1,23.1,21.0,21.0,20.7,20.4,20.3 (C
4 ', C
8 ', C
12 ', C
13 ', C
4 ' a, C
8 ' a, C
12 ' a, C
2a), 20.4,20.3,20.3,20.3 (CH
3, ethanoyl), 13.3,12.6 (C
7a, C
8b).
MS (ESI+C): m/z:1515.6[2M+Na]
+, 55%, 769.4[M+Na]
+, 100%, 764.1[M+NH
4]
+, 40%, 747.1[M+H]
+, 45%; HRMS (FAB, nitrobenzyl alcohol) theoretical value C
42H
67O
11[M+H]
+: 747.4683. actual value: 747.46790.
(6) synthetic (compound 2) of 8-(β-D-pyranoglucose)-ε-vitamin-E:
Operation is identical with embodiment 1 corresponding part step (6), obtains 8-(β-D-pyranoglucose)-ε-vitamin-E (compound 2), productive rate 89%.
Compound 2 solvabilities are: being slightly soluble in water, very easily being dissolved in acetone, methyl alcohol, pyridine, DMSO, is moderate solubility in chloroform.
Compound 2 test results are as follows:
The red-brown solid, Rf=0.60 (developping agent is an ethyl acetate); [α]
D 25=+18.8 (c=0.74, acetone).
Because compound 2 is for mixture that a plurality of chiral centres are arranged with because the steric hindrance relation makes glycosidic link (C-C key) not rotate freely, even cause under hot conditions [
1H-NMR (DMSO-d
6, 90 ℃, 500MHz),
13C-NMR (DMSO-d
6, 90 ℃, 125 MHz)] can not obtain nuclear magnetic resonance spectrum clearly.
MS(ESI+C):m/z:1179.4[2M+Na]
+(100%),601.4[M+Na]
+(45%).
(ESI-C):m/z:1191.2[2M+Cl]
-(60%),623.1[M+HCOO]
-(100%),577.3[M-H]
-(45%).
(7) 8-(2,3,4,6-four-O-ethanoyl-β-D-pyranoglucose)-6-hydroxyl-2,2,5,7-tetramethyl-benzo dihydropyrane synthetic:
Operation is identical with embodiment 1 corresponding part step (7), obtains 8-(2,3,4,6-four-O-ethanoyl-β-D-pyranoglucose)-6-hydroxyl-2,2,5,7-tetramethyl-benzo dihydropyrane, and productive rate is 48.2%.
The product test result is as follows:
White foam, (developping agent is sherwood oil and ethyl acetate=2: 1 to Rf=0.21, v/v); [α]
D 25=-1.1 (c=0.8, methylene dichloride);
1H-NMR (DMSO-d
6, 120 ℃, 500MHz): 7.00 (s, 1H, Ar-OH), 5.65 (br triplet, 1H, H
2 '), 5.24 (t, 1H, J=9.1,9.5Hz, H
3 '), 5.11 (br doublet, 1H, H
1 '), 5.07 (t, 1H, J=9.5,9.8Hz, H
4 '), 4.14 (d, 2H, J=3.5Hz, H
6a ', H
6b '), 3.91 (dt, 1H, J=9.8,3.8Hz, H
5 '), 2.58 (t, 2H, J=6.9Hz, H
4ab), 2.27,2.08 (2s, 6H, Me
5a, Me
7a), 2.03,2.00,1.95,1.71 (4s, 12H, 4 ethanoyl), 1.77 (t, 2H, J=6.9,6.6Hz, H
3ab), 1.33,1.29 (2s, 6H, Me
2a, Me
2b).
13C-NMR (DMSO-d
6, 120 ℃, 125MHz)): 170.5,170.2,169.9,169.2 (C=O, ethanoyl), 146.8,1 46.5 (C
6, C
8a),
*125.3,125.1,120.4,118.3 (C
5, C
7, C
8, C
4a),
*76.0,76.0,74.5,7 1.7,70.0 (C
1 ', C
2 ', C
3 ', C
4 ', C
5 '),
*73.5 (C
2), 63.4 (C
6 '), 33.6,21.4 (C
3, C
4),
*27.6,27.0 (C
2a, C
2b), 21.4,21.0,21.0,20.8 (CH
3, ethanoyl), 13.3,12.6 (Me
7a, Me
8b).
Ultimate analysis (C
27H
36O
11): theoretical value: C, 60.44; H, 6.76; O, 32.80. actual value: C, 60.92; H, 7.05; O, 31.23
(8) 8-(β-D-pyranoglucose)-6-hydroxyl-2,2,5,7-tetramethyl-benzo dihydropyrane (compound 4) synthetic:
Operation is identical with embodiment 1 corresponding part step (8), obtains 8-(β-D-pyranoglucose)-6-hydroxyl 2,2,5,7-tetramethyl-benzo dihydropyrane (compound 4), and productive rate is 93%.
Compound 4 solvabilities are, and are water-soluble, very easily are dissolved in acetone, methyl alcohol, pyridine, DMSO, are slightly soluble in chloroform.Its test result is as follows:
White solid, Rf=0.19 (developping agent is an ethyl acetate); [α]
D 25=+18.3 (c=0.6, methyl alcohol);
1H-NMR(DMSO-d
6+D
2O,90℃,500MHz):4.68(br?signal,1H,H
1’),3.86(br?signal,1H,H
2’),3.71(dd,1H,J=2.3,11.7Hz,H
6’a),3.50(dd,1H,J=5.1,11.7Hz,?H
6’b),3.30-3.20(m,3H?,H
3’,H
4’,H
5’),2.56(t.2H?,J=6.6,6.3Hz,H
4a,b),2.22,2.06(2s,6H,Me
5a,Me
7a),1.74(t,2H,J=6.6,6.0Hz,H
3a,b),1.25,1.21(2s,6H,Me
2a,Me
2b)
13C-NMR(DMSO-d
6+D
2O,90℃,125MHz):147.0,146.4(C
6,C
8a),124.9,123.9,123.8,118.2(C
4a,C
5,C
7,C
8),81.6,80.0,72.9,71.8,71.8(C
1’,C
2’,C
3’,C
4’,C
5’),73.2(C
2),62.9(C
6’),33.6(C
3),27.7,26.7(C
2a,C
2b),21.5(C
4),13.8,12.6(C
5a,C
7a).
MS(ESI+C)m/z=759.0[2M+Na]
+(100%),391.1[M+Na]
+(27%)。
Claims (3)
3, derivative as claimed in claim 1, it is characterized in that, described derivative is 5-(β-D-pyranoglucose)-γ-vitamin-E, 8-(β-D-pyranoglucose)-ε-vitamin-E, 5-(β-D-pyranoglucose)-6-hydroxyl-2,2,7,8-tetramethyl-benzo dihydropyrane or 8-(β-D-pyranoglucose)-6-hydroxyl-2,2,5,7-tetramethyl-benzo dihydropyrane.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100263775A CN100334080C (en) | 2005-06-01 | 2005-06-01 | Benzo-dihydropyran glycoside derivatives |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100263775A CN100334080C (en) | 2005-06-01 | 2005-06-01 | Benzo-dihydropyran glycoside derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1699356A CN1699356A (en) | 2005-11-23 |
CN100334080C true CN100334080C (en) | 2007-08-29 |
Family
ID=35475626
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2005100263775A Expired - Fee Related CN100334080C (en) | 2005-06-01 | 2005-06-01 | Benzo-dihydropyran glycoside derivatives |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100334080C (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR112013004546B1 (en) | 2010-08-26 | 2019-04-30 | Dsm Ip Assets B.V. | Process for the manufacture of 2,3,5-trimethylhydro-p-benzoquinone |
WO2019012000A1 (en) * | 2017-07-12 | 2019-01-17 | Dsm Ip Assets B.V. | Novel synthesis of intermediates for the preparation of alpha-tocopherol |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1042911A (en) * | 1988-11-14 | 1990-06-13 | 默里尔多药物公司 | Cardioprotective tocopherol anologs |
CN1053062A (en) * | 1990-01-05 | 1991-07-17 | 卫材株式会社 | New vitamin e derivative and preparation method thereof |
WO2000016772A1 (en) * | 1998-09-23 | 2000-03-30 | Research Development Foundation | Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
-
2005
- 2005-06-01 CN CNB2005100263775A patent/CN100334080C/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1042911A (en) * | 1988-11-14 | 1990-06-13 | 默里尔多药物公司 | Cardioprotective tocopherol anologs |
CN1053062A (en) * | 1990-01-05 | 1991-07-17 | 卫材株式会社 | New vitamin e derivative and preparation method thereof |
WO2000016772A1 (en) * | 1998-09-23 | 2000-03-30 | Research Development Foundation | Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
Also Published As
Publication number | Publication date |
---|---|
CN1699356A (en) | 2005-11-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SU902666A3 (en) | Method of preparing pleuromutiline glycoside derivatives | |
Sato et al. | Environmentally friendly C-glycosylation of phloroacetophenone with unprotected D-glucose using scandium (III) trifluoromethanesulfonate in aqueous media: key compounds for the syntheses of mono-and di-C-glucosylflavonoids | |
EP0141057A1 (en) | Novel 4'-demethyl-4-epipodophyllotoxin derivatives, a process for their preparation and their use as medicaments | |
Murakami et al. | Studies on the constituents of Japanese and Chinese crude drugs. IV. On the Constituents of Pueraria root.(2) | |
CN104496871B (en) | A kind of preparation method of Tacalcitol | |
CN100334080C (en) | Benzo-dihydropyran glycoside derivatives | |
CN115073406B (en) | Eucalyptus type sesquiterpene lactone TBA derivative and application thereof | |
Inazu et al. | Glucosylation using glucopyranosyl dimethylphosphinothioate | |
CN1255502A (en) | Rebescensine A derivatives and preparing process thereof | |
Koeppen | Synthesis of neohesperidose | |
Khersonsky et al. | (±)-1, 2: 5, 6-Di-O-isopropylidene-myo-inositol and (±)-6-O-benzoyl-1, 2: 4, 5-di-O-isopropylidene-myo-inositol: a practical preparation of key intermediates for myo-inositol phosphates | |
CH640869A5 (en) | SUBSTITUTED ANTITUMORANTHRACYCLINE AND METHOD FOR THE PRODUCTION THEREOF. | |
Sasaki et al. | Synthesis of metal furoylacetonates and their SE reactions. I. Heteroaromaticity | |
Kumazawa et al. | Regioselective acetyl transfer from the aglycon to the sugar in C-glycosylic compounds facilitated by silica gel | |
CN101198616B (en) | Method for the synthesis of anthocyanins | |
CN101250098A (en) | Method for preparing 4'-hydroxy-2,6-methylenedioxy dihydrocharcone | |
SU1378784A3 (en) | Method of producing anthracyclineglycosides | |
CN105801350B (en) | The synthetic method of diarylcarbinols class compound | |
CN101250099B (en) | Method for preparing 4'-hydroxy-2,4-methylenedioxy dihydrocharcone | |
Tsukayama et al. | Regioselective synthesis of prenylisoflavones. Syntheses of allolicoisoflavone A, 2, 3-dehydrokievitone, and related compounds | |
CN112939920B (en) | Preparation method of dracorhodin A or dracorhodin B | |
CN114644678B (en) | Glucuronide compound, preparation method and application thereof | |
CN101182289B (en) | 4'-hydroxy-4,6'-dimethoxy dihydrocharcone and method for synthesizing the same | |
CN111606897B (en) | Catechin-amantadine coupling compound and preparation method and application thereof | |
KR100966027B1 (en) | The novel preparation method of decursin and decursin analoges |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20070829 Termination date: 20100601 |